Royal Bank of Canada »

Eikon Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Eikon Therapeutics (EIKN) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Eikon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eikon Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eikon Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2026-06-30 $36k 2.8k 12.76

More positions owned by Royal Bank of Canada

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Rbc Cad (RY)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Toronto Dominion Bk Ont Com New (TD)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Bank Of Montreal Cadcom (BMO)
Alphabet Cap Stk Cl C (GOOG)
Cibc Cad (CM)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)

View all positions for Royal Bank of Canada

Top funds holding Eikon Therapeutics

FMR
BlackRock
Foresite Capital Management IV
Merck & Co
Foresite Capital Management V
Capital World Investors
T. Rowe Price Associates
Vanguard Capital Management
EcoR1 Capital
Alliancebernstein
Geode Capital Management
Baker Bros. Advisors
Soros Capital Management
StepStone
Canada Pension Plan Investment Board

View all funds holding Eikon Therapeutics